Blackstone Medical, EnsoData partner on home sleep testing
By HME News Staff
Updated 10:19 AM CDT, Thu April 17, 2025
MADISON, Wis. – Blackstone Medical Services (BMS), a Medicare-approved, JCAHO-accredited and nationally recognized IDTF for home sleep testing, has partnered with EnsoData, an innovator in AI healthtech solutions, to offer improved accessibility to diagnosis and treatment for the millions of patients currently living with undiagnosed sleep apnea. BMS leverages EnsoData’s FDA-cleared, EnsoSleep PPG home sleep testing solution to equip primary care physicians with an effective and efficient method to reach patients suffering with sleep disorders. By simplifying the identification, diagnosis, and treatment of sleep-related conditions, BMS is helping accelerate patient care, improve patient outcomes, and reduce healthcare costs. “Our partnership with EnsoData allows us to provide an affordable, accessible at-home solution that is paving the way for fast, accurate diagnoses and better health outcomes nationwide,” said Vick Tipnes, Blackstone Medical CEO. Many patients face significant barriers in accessing healthcare, particularly those who live in rural or underserved areas, say the companies. “As sleep medicine evolves, the role of accessible technology has never been more critical,” said Justin Mortara, Ph.D., EnsoData CEO. “EnsoSleep PPG provides BMS with an avenue to reach more patients, no matter their location or ability to visit traditional sleep labs.”
Comments